News
News

The latest updates from AFAR.

Industry News: NPR Affirms the Pressing Need for AFAR’s Programs

Oct 17
2014

Industry News: NPR Affirms the Pressing Need for AFAR’s Programs

A recent broadcast on NPR’s Morning Edition helped underscore the pressing need for AFAR’s grant opportunities by highlighting how steep competition for federal grants has impacted researcher scientists. NPR reported that federal funding for biomedical research has declined by more than 20% over the past decade. This means there are far more scientists competing for grants than there is money to support them. The crunch is especially tight for new investigators who have yet to build esteem in their fields and for scientists hoping to pursue new, unexplored avenues with their research projects. Several of AFAR&rsquo…


View MoreREAD MORE


Grantee in the News: Beeson Scholar P. Muali Doraiswamy Praises New Alzheimer’s Findings in NY Times

Oct 15
2014

Grantee in the News: Beeson Scholar P. Muali Doraiswamy Praises New Alzheimer’s Findings in NY Times

On October 12, 2014, the New York Times quoted 1996 Paul Beeson Career Development Awards in Aging Research Scholar, Dr. P. Muali Doraiswamy for his expert opinion on a new finding in the field of Alzheimer’s disease research. Investigators at Massachusetts General Hospital have successfully replicated Alzheimer’s disease inflected human brain cells in a petri dish.  Dr. Doraiswamy believes that this discovery is “a giant step forward” because it will allow researchers to more efficiently study the disease and test new treatments.  P. Murali Doraiswamy, M.D., is a Professor in the Translational Neuroscience…


View MoreREAD MORE


Board Member in the News: Watch Deputy Scientific Director Nir Barzilai’s Tedx Talk

Oct 10
2014

Board Member in the News: Watch Deputy Scientific Director Nir Barzilai’s Tedx Talk

On September 27th, 2014, AFAR’s Deputy Science Director and two-time grantee, Nir Barzilai, M.D. presented at TedxGramercy’s “Grit” event in New York City. In his talk, “How to Die Young at a Very Old Age,” Dr. Barzilai underscores aging is a connecting risk factor behind the growing rates of diseases such as cancer, Alzheimer’s disease, Parkinson’s disease, and heart disease.  He explains how through his work studying the genetic make-up of healthy centenarians and their families, he is unlocking clues that may help postpone the onset of…


View MoreREAD MORE


AFAR Event: 2014 Regional Awards Dinner

Oct 8
2014

AFAR Event: 2014 Regional Awards Dinner

Please join AFAR as we honor outstanding leaders in aging research at  REGIONAL AWARDS DINNER WEDNESDAY, NOVEMBER 12, 2014 The Lotos Club, 5 East 66th Street, NY, NY 6:30 pm Cocktails | 7:30 pm Ticketed Dinner presenting the following AWARDS OF DISTINCTION:   CHAIRMAN’S AWARD Andrew Sieg Managing Director and Head of Global Wealth & Retirement Solutions, Bank of America Merrill Lynch   HONORARY LEADERSHIP AWARD Corinne H. Rieder, EdD Executive Director and Treasurer, The John A. Hartford Foundation   IRVING S. WRIGHT AWARD Terrie Fox Wetle, PhD Dean, School of Public Health, Professor of Health…


View MoreREAD MORE


Grantees in the News: AFAR Grantees Weigh-in on Longevity-Extending Drugs

Oct 8
2014

Grantees in the News: AFAR Grantees Weigh-in on Longevity-Extending Drugs

On October 2nd, 2014, The Independent sited two distinguished AFAR grantees:  AFAR’s Deputy Scientific Director and two-time grant award recipient, Nir Barzilai, M.D., and 2003 AFAR Research Award and 2008 Julie Martin Mid-Career Award in Aging Research recipient, Brian Kennedy, Ph.D. Dr. Barzilai and Dr. Kennedy commented on three drugs that have already been approved for human use for various ailments and have improved immunity response and increased lifespan in animal models.  For example, the type 2 diabetes medicine Metformin has been shown to extend the average lifespan of small animals by 5 percent and is…


View MoreREAD MORE




BACK TO TOPBACK TO TOP